ArticleEuropean journal of nuclear medicine and molecular imaging2021

Authors' reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?

Ian Alberts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.